GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Accumulated Depreciation

Artrya (ASX:AYA) Accumulated Depreciation : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Artrya Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Artrya's quarterly accumulated depreciation increased from Dec. 2023 (A$0.00 Mil) to Jun. 2024 (A$-1.11 Mil) but then stayed the same from Jun. 2024 (A$-1.11 Mil) to Dec. 2024 (A$0.00 Mil).

Artrya's annual accumulated depreciation increased from Jun. 2022 (A$-0.16 Mil) to Jun. 2023 (A$-0.56 Mil) and increased from Jun. 2023 (A$-0.56 Mil) to Jun. 2024 (A$-1.11 Mil).


Artrya Accumulated Depreciation Historical Data

The historical data trend for Artrya's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Accumulated Depreciation Chart

Artrya Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Accumulated Depreciation
- -0.16 -0.56 -1.11

Artrya Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accumulated Depreciation Get a 7-Day Free Trial - -0.56 - -1.11 -

Artrya Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Artrya Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Artrya's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Artrya Business Description

Traded in Other Exchanges
N/A
Address
1257 Hay Street, West Perth, Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines